Quantum Pharmaceutical Group has teamed up with the South West Yorkshire Partnership NHS Foundation Trust and Rowlands Pharmacy to evaluate the effectiveness of the Biodose Connect medicines delivery system in helping people with demential to stick to their treatment regimens.

Rowlands Pharmacies in South West Yorkshire are providing an integrated Biodose Connect dispensing service with tailored reviews, advice and interventions to support participating patients and their carers.

Biodose Connect enables live, remote monitoring and management of patient adherence, making it possible to identify missed doses quickly and make prompt interventions.

Professor Stephen Curran, consultant in old age psychiatry at South West Yorkshire Partnership NHS Foundation Trust, says: “Poor medicines adherence for people experiencing dementia can lead to a range of difficulties. Patients can accidentally overdose, miss doses or discontinue treatment without any consultation with their GP, all of which can be highly detrimental to their health and well-being and costly to the NHS and social care budgets.

“In a community setting Biodose Connect could significantly reduce these issues of poor adherence, preventing unnecessary, distressing and costly hospital admissions by providing better and safer outcomes for patients.”